HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia
Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0922
Full Text
Open PDFAbstract
Available in full text
Date
February 27, 2019
Authors
Publisher
American Association for Cancer Research (AACR)